Cargando…
Soluble Sema4D in Plasma of Head and Neck Squamous Cell Carcinoma Patients Is Associated With Underlying Non-Inflamed Tumor Profile
Semaphorin 4D (Sema4D) is a glycoprotein that is expressed by several tumors and immune cells. It can function as a membrane bound protein or as a cleaved soluble protein (sSema4D). We sought to investigate the translational potential of plasma sSema4D as an immune marker in plasma of patients with...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991916/ https://www.ncbi.nlm.nih.gov/pubmed/33776991 http://dx.doi.org/10.3389/fimmu.2021.596646 |
_version_ | 1783669270379495424 |
---|---|
author | Younis, Rania H. Ghita, Ioana Elnaggar, Manar Chaisuparat, Risa Theofilou, Vasileios Ionas Dyalram, Donita Ord, Robert A. Davila, Eduardo Tallon, Luke J. Papadimitriou, John C. Webb, Tonya J. Bentzen, Søren M. Lubek, Joshua E. |
author_facet | Younis, Rania H. Ghita, Ioana Elnaggar, Manar Chaisuparat, Risa Theofilou, Vasileios Ionas Dyalram, Donita Ord, Robert A. Davila, Eduardo Tallon, Luke J. Papadimitriou, John C. Webb, Tonya J. Bentzen, Søren M. Lubek, Joshua E. |
author_sort | Younis, Rania H. |
collection | PubMed |
description | Semaphorin 4D (Sema4D) is a glycoprotein that is expressed by several tumors and immune cells. It can function as a membrane bound protein or as a cleaved soluble protein (sSema4D). We sought to investigate the translational potential of plasma sSema4D as an immune marker in plasma of patients with head and neck squamous cell carcinoma (HNSCC). Paired peripheral blood and tumor tissue samples of 104 patients with HNSCC were collected at the same time point to allow for real time analysis. Scoring of the histological inflammatory subtype (HIS) was carried out using Sema4D immunohistochemistry on the tumor tissue. sSema4D was detected in plasma using direct ELISA assay. Defining elevated sSema4D as values above the 95(th) percentile in healthy controls, our data showed that sSema4D levels in plasma were elevated in 25.0% (95% CI, 16.7–34.9%) of the patients with HNSCC and showed significant association with HIS immune excluded (HIS-IE) (p = 0.007), Sema4D(+ve) tumor cells (TCs) (p = 0.018) and PD-L1(+ve) immune cells (ICs) (p = 0.038). A multi-variable logistic regression analysis showed that HIS was significantly (P = 0.004) associated with elevated sSema4D, an association not explained by available patient-level factors. Using the IO-360 nanoString platform, differential gene expression (DGE) analysis of 10 HNSCC tumor tissues showed that patients with high sSema4D in plasma (HsS4D) clustered as IFN-γ negative tumor immune signature and were mostly HIS-IE. The IC type in the HsS4D paired tumor tissue was predominantly myeloid, while the lymphoid compartment was higher in the low sSema4D (LsS4D). The Wnt signaling pathway was upregulated in the HsS4D group. Further analysis using the IO-360, 770 gene set, showed significant non-inflamed profile of the HsS4D tumors compared to the LsS4D. In conclusion, our data reveals an association between sSema4D and the histological inflammatory subtype. |
format | Online Article Text |
id | pubmed-7991916 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79919162021-03-26 Soluble Sema4D in Plasma of Head and Neck Squamous Cell Carcinoma Patients Is Associated With Underlying Non-Inflamed Tumor Profile Younis, Rania H. Ghita, Ioana Elnaggar, Manar Chaisuparat, Risa Theofilou, Vasileios Ionas Dyalram, Donita Ord, Robert A. Davila, Eduardo Tallon, Luke J. Papadimitriou, John C. Webb, Tonya J. Bentzen, Søren M. Lubek, Joshua E. Front Immunol Immunology Semaphorin 4D (Sema4D) is a glycoprotein that is expressed by several tumors and immune cells. It can function as a membrane bound protein or as a cleaved soluble protein (sSema4D). We sought to investigate the translational potential of plasma sSema4D as an immune marker in plasma of patients with head and neck squamous cell carcinoma (HNSCC). Paired peripheral blood and tumor tissue samples of 104 patients with HNSCC were collected at the same time point to allow for real time analysis. Scoring of the histological inflammatory subtype (HIS) was carried out using Sema4D immunohistochemistry on the tumor tissue. sSema4D was detected in plasma using direct ELISA assay. Defining elevated sSema4D as values above the 95(th) percentile in healthy controls, our data showed that sSema4D levels in plasma were elevated in 25.0% (95% CI, 16.7–34.9%) of the patients with HNSCC and showed significant association with HIS immune excluded (HIS-IE) (p = 0.007), Sema4D(+ve) tumor cells (TCs) (p = 0.018) and PD-L1(+ve) immune cells (ICs) (p = 0.038). A multi-variable logistic regression analysis showed that HIS was significantly (P = 0.004) associated with elevated sSema4D, an association not explained by available patient-level factors. Using the IO-360 nanoString platform, differential gene expression (DGE) analysis of 10 HNSCC tumor tissues showed that patients with high sSema4D in plasma (HsS4D) clustered as IFN-γ negative tumor immune signature and were mostly HIS-IE. The IC type in the HsS4D paired tumor tissue was predominantly myeloid, while the lymphoid compartment was higher in the low sSema4D (LsS4D). The Wnt signaling pathway was upregulated in the HsS4D group. Further analysis using the IO-360, 770 gene set, showed significant non-inflamed profile of the HsS4D tumors compared to the LsS4D. In conclusion, our data reveals an association between sSema4D and the histological inflammatory subtype. Frontiers Media S.A. 2021-03-11 /pmc/articles/PMC7991916/ /pubmed/33776991 http://dx.doi.org/10.3389/fimmu.2021.596646 Text en Copyright © 2021 Younis, Ghita, Elnaggar, Chaisuparat, Theofilou, Dyalram, Ord, Davila, Tallon, Papadimitriou, Webb, Bentzen and Lubek http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Younis, Rania H. Ghita, Ioana Elnaggar, Manar Chaisuparat, Risa Theofilou, Vasileios Ionas Dyalram, Donita Ord, Robert A. Davila, Eduardo Tallon, Luke J. Papadimitriou, John C. Webb, Tonya J. Bentzen, Søren M. Lubek, Joshua E. Soluble Sema4D in Plasma of Head and Neck Squamous Cell Carcinoma Patients Is Associated With Underlying Non-Inflamed Tumor Profile |
title | Soluble Sema4D in Plasma of Head and Neck Squamous Cell Carcinoma Patients Is Associated With Underlying Non-Inflamed Tumor Profile |
title_full | Soluble Sema4D in Plasma of Head and Neck Squamous Cell Carcinoma Patients Is Associated With Underlying Non-Inflamed Tumor Profile |
title_fullStr | Soluble Sema4D in Plasma of Head and Neck Squamous Cell Carcinoma Patients Is Associated With Underlying Non-Inflamed Tumor Profile |
title_full_unstemmed | Soluble Sema4D in Plasma of Head and Neck Squamous Cell Carcinoma Patients Is Associated With Underlying Non-Inflamed Tumor Profile |
title_short | Soluble Sema4D in Plasma of Head and Neck Squamous Cell Carcinoma Patients Is Associated With Underlying Non-Inflamed Tumor Profile |
title_sort | soluble sema4d in plasma of head and neck squamous cell carcinoma patients is associated with underlying non-inflamed tumor profile |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991916/ https://www.ncbi.nlm.nih.gov/pubmed/33776991 http://dx.doi.org/10.3389/fimmu.2021.596646 |
work_keys_str_mv | AT younisraniah solublesema4dinplasmaofheadandnecksquamouscellcarcinomapatientsisassociatedwithunderlyingnoninflamedtumorprofile AT ghitaioana solublesema4dinplasmaofheadandnecksquamouscellcarcinomapatientsisassociatedwithunderlyingnoninflamedtumorprofile AT elnaggarmanar solublesema4dinplasmaofheadandnecksquamouscellcarcinomapatientsisassociatedwithunderlyingnoninflamedtumorprofile AT chaisuparatrisa solublesema4dinplasmaofheadandnecksquamouscellcarcinomapatientsisassociatedwithunderlyingnoninflamedtumorprofile AT theofilouvasileiosionas solublesema4dinplasmaofheadandnecksquamouscellcarcinomapatientsisassociatedwithunderlyingnoninflamedtumorprofile AT dyalramdonita solublesema4dinplasmaofheadandnecksquamouscellcarcinomapatientsisassociatedwithunderlyingnoninflamedtumorprofile AT ordroberta solublesema4dinplasmaofheadandnecksquamouscellcarcinomapatientsisassociatedwithunderlyingnoninflamedtumorprofile AT davilaeduardo solublesema4dinplasmaofheadandnecksquamouscellcarcinomapatientsisassociatedwithunderlyingnoninflamedtumorprofile AT tallonlukej solublesema4dinplasmaofheadandnecksquamouscellcarcinomapatientsisassociatedwithunderlyingnoninflamedtumorprofile AT papadimitrioujohnc solublesema4dinplasmaofheadandnecksquamouscellcarcinomapatientsisassociatedwithunderlyingnoninflamedtumorprofile AT webbtonyaj solublesema4dinplasmaofheadandnecksquamouscellcarcinomapatientsisassociatedwithunderlyingnoninflamedtumorprofile AT bentzensørenm solublesema4dinplasmaofheadandnecksquamouscellcarcinomapatientsisassociatedwithunderlyingnoninflamedtumorprofile AT lubekjoshuae solublesema4dinplasmaofheadandnecksquamouscellcarcinomapatientsisassociatedwithunderlyingnoninflamedtumorprofile |